Regenerative effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Beyond the original application approved by the U.S. Food and Drug Administration, recombinant human bone morphogenetic pro-tein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) treatment because of its bone remodeling enhancement proper-ties. The purpose of the study was to investigate the bone formation effect of rhBMP-2/absorbable collagen sponge (ACS) in patients with MRONJ. Materials and Methods: In this retrospective cohort study, 26 female patients diagnosed with MRONJ and who underwent mandibular se-questrectomy at Ajou University Dental Hospital from 2010 to 2018 were included. The experimental group was composed of 18 patients who received rhBMP-2/ACS after sequestrectomy, while the control group was composed of 8 patients who did not receive rhBMP-2/ACS after se-questrectomy. A total dose of 0.5 mg of rhBMP-2 was used in the experimental group at a concentration of 0.5 mg/mL. Follow-up panoramic X-rays were taken immediately after the surgery and more than 6 months after the surgery. Using those X-rays, a radiographic index of bone defect area was calculated using the modified Ihan Hren method, which measures radiographic density of the normal bone and the defect site. Results: This study suggests that rhBMP-2 contributes to new bone formation. The mean radiographic index immediately after surgery and more than 6 months after the surgery for the experimental group was 68.4% and 79.8%, respectively. The mean radiographic index immediately after surgery and more than 6 months after the surgery for the control group was 73.4% and 76.7%, respectively (Wilcoxon signed rank test, P>0.05). The mean radiographic index increased 11.4% in the experimental group and 3.27% in the control group (Mann–Whitney U-test, P<0.05). Conclusion: Based on the results, use of rhBMP-2/ACS on bone defect sites after sequestrectomy could be a successful strategy for treatment of MRONJ patients.
Abstract
Objectives: Beyond the original application approved by the U.S. Food and Drug Administration, recombinant human bone morphogenetic pro-tein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) treatment because of its bone remodeling enhancement proper-ties. The purpose of the study was to investigate the bone formation effect of rhBMP-2/absorbable collagen sponge (ACS) in patients with MRONJ. Materials and Methods: In this retrospective cohort study, 26 female patients diagnosed with MRONJ and who underwent mandibular se-questrectomy at Ajou University Dental Hospital from 2010 to 2018 were included. The experimental group was composed of 18 patients who received rhBMP-2/ACS after sequestrectomy, while the control group was composed of 8 patients who did not receive rhBMP-2/ACS after se-questrectomy. A total dose of 0.5 mg of rhBMP-2 was used in the experimental group at a concentration of 0.5 mg/mL. Follow-up panoramic X-rays were taken immediately after the surgery and more than 6 months after the surgery. Using those X-rays, a radiographic index of bone defect area was calculated using the modified Ihan Hren method, which measures radiographic density of the normal bone and the defect site. Results: This study suggests that rhBMP-2 contributes to new bone formation. The mean radiographic index immediately after surgery and more than 6 months after the surgery for the experimental group was 68.4% and 79.8%, respectively. The mean radiographic index immediately after surgery and more than 6 months after the surgery for the control group was 73.4% and 76.7%, respectively (Wilcoxon signed rank test, P>0.05). The mean radiographic index increased 11.4% in the experimental group and 3.27% in the control group (Mann–Whitney U-test, P<0.05). Conclusion: Based on the results, use of rhBMP-2/ACS on bone defect sites after sequestrectomy could be a successful strategy for treatment of MRONJ patients.
참고문헌 (17)
- 이정근, "Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report", 대한구강악안면외과학회지, 39(1), pp.9~13 (2013), 대한구강악안면외과학회
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72, pp.1938~1956 (2014)
- Gómez Font R, "Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update", Med Oral Patol Oral Cir Bucal, 13, pp.E318~E324 (2008)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw -2009 update", Aust Endod J, 35, pp.119~130 (2009)
- Vescovi P, "Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw", Int J Dent, 2014, pp.107690~ (2014)
- Cicciù M, "Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw", J Craniofac Surg, 23, pp.784~788 (2012)
- Bagan J, "Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates(BRONJ) : a concise update", Oral Oncol, 45, pp.551~554 (2009)
- Park JH, "Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw?", J Oral Maxillofac Surg, 75, pp.1176~1184 (2017)
- Freitas RM, "Alveolar ridge and maxillary sinus augmentation using rhBMP-2: a systematic review", Clin Implant Dent Relat Res, 17(Suppl 1), pp.e192~e201 (2015)
- Carter TG, "Off-label use of recombinant human bone morphogenetic protein-2(rhBMP-2)for reconstruction of mandibular bone defects in humans", J Oral Maxillofac Surg, 66, pp.1417~1425 (2008)
- Hwang DY, "Bone regenerative effect of recombinant human bone morphogenetic protein-2 after cyst enucleation. Version 2", Maxillofac Plast Reconstr Surg, 38, pp.22~ (2016)
- Chenard KE, "Bone morphogenetic proteins in craniofacial surgery : current techniques, clinical experiences, and the future of personalized stem cell therapy", J Biomed Biotechnol, 2012, pp.601549~ (2012)
- Li RH, "Delivering on the promise of bone morphogenetic proteins", Trends Biotechnol, 19, pp.255~265 (2001)
- Geiger M, "Collagen sponges for bone regeneration with rhBMP-2", Adv Drug Deliv Rev, 55, pp.1613~1629 (2003)
- Russell RG, "Mechanisms of action of bisphosphonates : similarities and differences and their potential influence on clinical efficacy", Osteoporos Int, 19, pp.733~759 (2008)
- Ihan Hren N, "Spontaneous bone healing of the large bone defects in the mandible", Int J Oral Maxillofac Surg, 37, pp.1111~1116 (2008)
- 임정훈, "악골 내 발생한 낭종의 적출술 후 자발적인 골의 재생에 대한 파노라마 방사선 분석", Maxillofacial Plastic Reconstructive Surgery, 31(3), pp.229~236 (2009), 대한악안면성형재건외과학회